The suppression of cell growth with alectinib + TNKS1/2 inhibitor was similar to those observed with XAV939 in neuroblastoma cell lines38, lung adenocarcinoma cells39, and small cell lung cancer cells in vitro40. Here, TNKS is linked to lung adenocarcinoma.